2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride
C22H35Cl2N3O — CID 119872418
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride (PubChem CID 119872418) has the molecular formula C22H35Cl2N3O and a molecular weight of 428.45 g/mol. Its IUPAC name is 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride.
Molecular Properties
| Compound Name | 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride |
|---|---|
| PubChem CID | 119872418 |
| Molecular Formula | C22H35Cl2N3O |
| Molecular Weight | 428.45 g/mol |
| Exact Mass | 427.22 |
| IUPAC Name | 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(3-methylbutyl)-1,3-dihydroisoindol-4-yl]acetamide;dihydrochloride |
| SMILES | CC(C)CCN1Cc2cccc(NC(=O)CC3CC4CCC(C3)N4)c2C1.Cl.Cl |
| InChI | InChI=1S/C22H33N3O.2ClH/c1-15(2)8-9-25-13-17-4-3-5-21(20(17)14-25)24-22(26)12-16-10-18-6-7-19(11-16)23-18;;/h3-5,15-16,18-19,23H,6-14H2,1-2H3,(H,24,26);2*1H |
| InChIKey | HXBCVFVOGLUTEV-UHFFFAOYSA-N |
| XLogP | 4.75 |
| TPSA | 44.37 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.45 |
| LogP ≤ 5 | 4.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119872418 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.